Literature DB >> 22192785

Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.

Gunisetty Sivaram1, Santosh K Tiwari, Avinash Bardia, Farha Anjum, Satti Vishnupriya, Aejaz Habeeb, Aleem A Khan.   

Abstract

Ulcerative colitis is a multifactorial disease in which genetic factors play a major role. Functional mutations in the genes related to innate immune response exacerbate mucosal damage coupled with persistent inflammation. The cytokine macrophage migration inhibitory factor (MIF), CD14, and Toll-like receptor 4 (TLR4) are the central players with clearly defined roles in inflammation. The aim of this study was to investigate the association between MIF-173G > C, CD14-159C > T, and TLR4-299A > G polymorphisms and mononuclear cell expression in patients with ulcerative colitis (UC). Genotyping of MIF-173G > C, CD14-159C > T, and TLR4-299A > G polymorphisms was performed by amplification refractory mutation system-polymerase chain reaction and allele-specific amplification in 139 and 176 patients with UC and controls, respectively. Simultaneously, the expression levels of intracellular MIF, mCD14, and mTLR4 were determined in mononuclear cells using a flow cytometer. Polymorphisms in CD14-159C > T and TLR4-299A > G significantly affected mCD14 and mTLR4 expression levels and also increased susceptibility to UC. Although intracellular MIF expression levels differed among patient and control groups, the polymorphism in MIF 173G > C was not observed to be associated with a risk of UC.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192785     DOI: 10.1016/j.humimm.2011.12.006

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

Review 1.  Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Authors:  James D Falvey; Robert W Bentley; Tony R Merriman; Mark B Hampton; Murray L Barclay; Richard B Gearry; Rebecca L Roberts
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

2.  Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.

Authors:  Jianfeng Yang; Yanqi Li; Xiaofeng Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Yang Cheng; Yun Zhu; Xiuping Huang; Wei Zhang; Zelong Han; Side Liu
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 4.  Role of TLR4  rs4986790A>G and rs4986791C>T Polymorphisms in the Risk of Inflammatory Bowel Disease.

Authors:  Ran Ao; Ying Wang; Dao-Rong Zhnag; Ya-Qi Du
Journal:  Gastroenterol Res Pract       Date:  2015-05-18       Impact factor: 2.260

5.  Association of the interleukin-22 genetic polymorphisms with ulcerative colitis.

Authors:  Hong Gang Chi; Xue Bao Zheng; Zhu Guo Wu; Shi Xue Dai; Zheng Wan; Ying Zou
Journal:  Diagn Pathol       Date:  2014-10-09       Impact factor: 2.644

6.  Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis.

Authors:  Zhengting Wang; Jiajia Hu; Rong Fan; Jie Zhou; Jie Zhong
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

7.  The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis.

Authors:  Yongchun Shen; Shujin Guo; Ting Yang; Liuqun Jia; Lei Chen; Jing An; Tao Wang; Fuqiang Wen
Journal:  Int J Mol Sci       Date:  2013-05-28       Impact factor: 5.923

8.  Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.

Authors:  Ning-Bo Hao; Ya Fei He; Gang Luo; Xin Yong; Yao Zhang; Shi-Ming Yang
Journal:  BMJ Open       Date:  2013-12-23       Impact factor: 2.692

Review 9.  The role of MIF in type 1 and type 2 diabetes mellitus.

Authors:  Yuriko I Sánchez-Zamora; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2014-01-02       Impact factor: 4.011

10.  IRGM rs13361189 polymorphism may contribute to susceptibility to Crohn's disease: A meta-analysis.

Authors:  Yao Lu; Chun-Yu Li; Shu-Sen Lin; Peng Yuan
Journal:  Exp Ther Med       Date:  2014-05-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.